Oral Abstract
Is Discontinuation of Antiplatelet Therapy after 6 Months Safe in Patients with Drug-Eluting Stents Undergoing Noncardiac Surgery?
Mihir Bakhru, Wael Saber, Daniel Brotman, Deepak Bhatt, Ashish Aneja, Katherina Tillan-Martinez and Amir Jaffer
Cleveland Clinic Journal of Medicine September 2006, 73 (9 esuppl 1) S23;
Mihir Bakhru
1Division of Medicine, Internal Medicine Residency Program, Cleveland Clinic, Cleveland, OH
Wael Saber
2Department of Hematology, University of Madision, WI
Daniel Brotman
3Department of Medicine, Johns Hopkins Hospital, Baltimore, MD
Deepak Bhatt
4Departments of Cardiovascular Medicine
Ashish Aneja
5General Internal Medicine, Cleveland Clinic, Cleveland, OH
Katherina Tillan-Martinez
5General Internal Medicine, Cleveland Clinic, Cleveland, OH
Amir Jaffer
5General Internal Medicine, Cleveland Clinic, Cleveland, OH


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Cleveland Clinic Journal of Medicine
Vol. 73, Issue 9 esuppl 1
1 Sep 2006
Is Discontinuation of Antiplatelet Therapy after 6 Months Safe in Patients with Drug-Eluting Stents Undergoing Noncardiac Surgery?
Mihir Bakhru, Wael Saber, Daniel Brotman, Deepak Bhatt, Ashish Aneja, Katherina Tillan-Martinez, Amir Jaffer
Cleveland Clinic Journal of Medicine Sep 2006, 73 (9 esuppl 1) S23;
Is Discontinuation of Antiplatelet Therapy after 6 Months Safe in Patients with Drug-Eluting Stents Undergoing Noncardiac Surgery?
Mihir Bakhru, Wael Saber, Daniel Brotman, Deepak Bhatt, Ashish Aneja, Katherina Tillan-Martinez, Amir Jaffer
Cleveland Clinic Journal of Medicine Sep 2006, 73 (9 esuppl 1) S23;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.